Search
for
Sort by
Research 181–210 of 1000+
- Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices
- Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis
- Most recent findings of curative drugs for lower urinary tract symptoms in clinical practice
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Recommended Articles
- The effective course of finasteride pretreatment in decreasing blood loss associated with TURP
- Moving Chemoprevention Forward into the Most Promising Areas of Study
- Clinical facts and curios
- Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction
- The Pharmacology of Regenerative Medicine
- A Review on change in chemical, morphological and therapeutic activity of honey
- Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction
- Anti-androgenic therapy with finasteride in patients with chronic heart failure – a retrospective propensity score based analysis
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Effects of 5-alpha reductase inhibitors
- Formulation of shampoo from Eclipta alba based on their antioxidant and antimicrobial activity
- Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia was Confirmed by Clinical Trial
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia?
- S90 Urethral PSA production after radical prostatectomy
- S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8)
- 1748 IS ANDROGENETIC ALOPECIA ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA? ANALYSIS OF 907 PATIENTS
- Endocrine control of benign prostatic hyperplasia
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Evaluation of hydro-alcoholic extract of Eclipta alba for its anticancer potential: An in vitro study
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Cetuximab-Associated Elongation of the Eyelashes
- Let astaxanthin be thy medicine